Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John G. Aunins currently holds 105,250 shares of Seres Therapeutics, Inc. (MCRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John G. Aunins has been a net seller of MCRB stock. They have purchased $0 and sold $3.9M worth of shares.
John G. Aunins's most recent insider trade was on Jan 26, 2020, when they sold 12,500 shares at $0.00 per share.
John G. Aunins serves as Executive at Seres Therapeutics, Inc. (MCRB). They have executed 30 insider transactions totaling $3.9M over their tenure at the company.
John G. Aunins holds the position of Executive at Seres Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
John G. Aunins has shown a selling trading pattern, with $0 in total purchases and $3.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John G. Aunins was on Apr 25, 2016, when they sold $595.4K worth of MCRB shares. This transaction involved 18,640 shares at $31.94 per share.
John G. Aunins currently owns 105,250 shares of Seres Therapeutics, Inc. (MCRB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John G. Aunins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John G. Aunins has 30 Form 4 filings on record as an insider at Seres Therapeutics, Inc..
Set alerts for John G. Aunins and 40,000+ other insiders.